title: [Gastrointestinal Cancers Symposium 2015: New analysis from PEAK study: Early, deep and sustained tumor shrinkage by panitumumab].
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000556:secondary; D066246:ErbB Receptors / Q000378:metabolism; D011905:Genes, ras / Q000502:physiology; D006801:Humans; D009362:Neoplasm Metastasis / Q000188:drug therapy; D000077544:Panitumumab
chemical_list: D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D000077544:Panitumumab; C512478:EGFR protein, human; D066246:ErbB Receptors